Treatment of Gout by Reduction of Uric Acid Production
Open Access
- 1 July 1966
- journal article
- research article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 25 (4) , 353-355
- https://doi.org/10.1136/ard.25.4.353
Abstract
A study was made of the clinical and biochemical effects of 3 types of drug in the reduction of uric acid production: caparase, oroturic acid, and the xanthine oxidase inhibitor, allopurinol. A pilot experiment with 4 cases of gout was followed by a long-term study of 29 cases treated with allopurinol alone and in combination with anturan. The findings suggest that allopurinol with Anturan is valuable in treating severe cases of gout and in helping to prevent renal damage. It may also be used alone with advantage in certain selected cases.This publication has 7 references indexed in Scilit:
- Studies with allopurinol (HPP) in patients with tophaceous goutArthritis & Rheumatism, 1965
- The effect of allopurinol (HPP) in the treatment of goutArthritis & Rheumatism, 1965
- Xanthine oxidase inhibitors in the management of goutArthritis & Rheumatism, 1965
- Effect of allopurinol (4-Hydroxypyrazolo-(3,4-d)pyrimidine) on serum and urinary uric acid in primary and secondary goutThe American Journal of Medicine, 1964
- 4-Hydroxypyrazolo (3,4-d) Pyrimidine (HPP) in the Treatment of GoutAnnals of the Rheumatic Diseases, 1964
- EFFECT OF OROTIC ACID ON METASTASIS OF MAMMARY TUMORS IN MICE1964
- Uricosuric Agents in the Treatment of GoutAnnals of the Rheumatic Diseases, 1960